DOCSLIB.ORG

Mitomycins Syntheses: a Recent Update

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mitomycins Syntheses: a Recent Update Mitomycins syntheses: a recent update Jean-Christophe Andrez Review Open Access Address: Beilstein Journal of Organic Chemistry 2009, 5, No. 33. Department of Chemistry, University of British Columbia, 2036 Main doi:10.3762/bjoc.5.33 Mall, Vancouver, BC, V6T1Z1, Canada Received: 09 January 2009 Email: Accepted: 28 May 2009 Jean-Christophe Andrez - [email protected] Published: 08 July 2009 Editor-in-Chief: J. Clayden Keywords: antitumour; bioactivity; mitomycin; mitosene; synthesis © 2009 Andrez; licensee Beilstein-Institut. License and terms: see end of document. Abstract Mitomycins are a class of very potent antibacterial and anti-cancer compounds having a broad activity against a range of tumours. They have been used in clinics since the 1960’s, and the challenges represented by their total synthesis have challenged generations of chemists. Despite these chemical and medicinal features, these compounds, in racemic form, have succumbed to total synthesis only four times over the last 30 years. Review Introduction The mitomycins pose unique challenges to the synthetic their apparent fragility, mitomycins were rapidly identified to chemist. As S. Danishefsky noted, “The complexity of the act as prodrugs and their unique activity was thought to problem arises from the need to accommodate highly inter- originate from their ability to transform in vivo to generate the active functionality in a rather compact matrix and to orches- active metabolite. This was followed by decades of investiga- trate the chemical progression such as to expose and maintain tions to understand in detail their singular mode of action. It vulnerable structural elements as the synthesis unfolds. The was found that the aziridine played a crucial role, allowing an synthesis of a mitomycin is the chemical equivalent of walking irreversible bis-alkylation of DNA [3]. The decisive role of the on egg shells.” aziridine is far from unusual since its presence in a small number of other naturally occurring molecules such as azino- The first discovery of a mitomycin (mitomycin C, Scheme 2, mycins [4,5], FR-900482 [6], maduropeptin [7], and compound 7) dated from 1958 [1]. Its structural elucidation was azicemicins [8] is accompanied by significant biological proper- remarkable at that time considering the presence of 4ties (Scheme 1) [3,9]. Mitomycin C, 7, the most potent mito- contiguous stereogenic carbons in the molecule. The tetracyclic mycin, has been used medicinally since the 1970’s for its pyrrolo-indole skeleton of a mitomycin is embellished with an activity against breast, stomach, oesophagus and bladder aziridine ring, a carbamoyl moiety and a bridged carbinolamine tumours [9]. Besides the well-known antibiotic and antitumour packed in a constrained architecture [2]. The presence of such a properties of these compounds [9-12], other semi-synthetic concentration of functional groups renders this molecule only derivatives were prepared for investigation in clinical trials [13, moderately stable to bases, acid and nucleophiles but particu- 14]. larly reactive in presence of reducing agents. Notwithstanding Page 1 of 36 (page number not for citation purposes) Beilstein Journal of Organic Chemistry 2009, 5, No. 33. Scheme 1: Aziridine containing natural products. Altogether, the biological features of the mitomycins and the well as other soft and solid tumours [22]. The seven most challenges represented by their total synthesis have continually abundant mitomycins (A to K) in nature are presented in drawn the attention of numerous brilliant chemists who Scheme 2. conceived many different routes for their synthesis. However, only four total syntheses have been achieved [15-20]. Also, this Since many synthetic attempts did not succeed in providing review will summarize the current state of the art concerning mitomycins per se but only close relatives of these molecules, a the chemistry and biology of mitomycins. It will show and special nomenclature has been elaborated for these compounds: comment on the methodologies that have been successfully structures of type 15, which do not contain an aziridine ring, but employed in total syntheses as well as approaches leading to mitomycin analogs. The review will focus on the synthetic liter- ature of the past 30 years. From time to time earlier references will be provided to give background information. The mito- mycin’s close cousins, the FR family (Scheme 1, compounds 3 and 4) will not be discussed, nor will the different strategies that have been employed to improve the efficacy of mitomycins in vivo by structure activity relationship studies. As a matter of fact, the natural products themselves are so sensitive that only minor modifications have been possible in connection with medicinal chemistry studies. Discussion 1. Mitomycin isolation and nomenclature Mitomycins are natural products isolated from extracts of genus Streptomyces, a filamentous gram-positive soil bacterium that produces a wide array of biologically active compounds, including over two-thirds of the commercially important natural-product metabolites [21]. Mitomycin C is extracted from the bacterium Streptomyces lavendulae and is far from the most known compound of the series. It has become one of the most effective drugs against non-small-cell lung carcinoma, as Scheme 2: Mitomycin structures and nomenclature. Page 2 of 36 (page number not for citation purposes) Beilstein Journal of Organic Chemistry 2009, 5, No. 33. Scheme 3: Base catalysed epimerization of mitomycin B. bear the p-quinone are called mitosanes or mitosenes depending reversibly deprotonates the activated C9 position to give the whether they are at the oxidation state of an indoline (Y1 or Y2 more stable isomer 18 (Scheme 3) [27]. The basis of this = H) or an indole (Y1 = Y2 = C=C). Compounds bearing an surmise was the finding that mitomycin B eliminates carbamic aziridine at C1 and C2 are described specifically as aziridi- acid at the C10 position in basic medium whereas the angular nomitosanes and aziridinomitosenes respectively. Compounds methoxy series (mitomycin C), which can not open to the amino possessing a hydroquinone (protected or not) in place of the ketone, needs a better leaving group (such as a sulfonate). original quinone are identified by inclusion of the prefix leuco in reference to the Greek word leukos (clear, white) and the lack 2. Biology of intense color usually specific of the corresponding quinone 2.1. Biosynthesis ring. A significant amount of information on the biosynthesis of mitomycin C has been accumulated since 1970 [28]. The The mitomycins A and C differ only by the substituents on the mitosane core was shown to be derived from combination of quinone ring and transformation from 6 to 7 is realized by 3-amino-5-hydroxybenzoic acid 20 (AHBA), D-glucosamine 21 simple treatment with ammonia [23,24]. The mitomycins F, 8, and carbamoyl phosphate (Scheme 4) [29-32]. The key interme- and porfiromycin, 9, are synthesized by methylation of the diate, AHBA, is also a common precursor to other anticancer aziridine of mitomycin A and mitomycin C, respectively. Mito- drugs, such as rifamycin and ansamycin. mycin G, 12, mitomycin H, 13, and mitomycin K, 14, are deriv- atives of this first series obtained by elimination of the 2.2. Mode of action carbamate at position 10 [25,26]. Mitomycin B, 10, and mito- Mitomycins are quinone antitumor antibiotics that exert their mycin D, 11, possess the opposite absolute configuration of the biological activity through DNA alkylation and cross-linking. asymmetric carbon C9. Interestingly, Hornemann proved that The success of mitomycin C in cancer treatment is due to a this carbon could be easily epimerized to give 9-epi-mitomycin great cytotoxic selectivity for hypoxic (O2-deficient) cells char- B, 19. This compound showed better activity than the non- acteristic of solid tumors [33,34]. Mitomycin C itself is indeed epimerized one. He proposed a based-catalyzed mechanism relatively unreactive toward DNA [35,36] but becomes remark- wherein the tetracyclic-pyrolido-indole structure 10 opens up ably reactive upon reduction (enzymatic, electrochemical or reversibly at the bridged carbinolamine junction to give the chemical) by the mechanism shown in Scheme 5 [37-39]. This eight-membered ring 17. The base, in this case DBU, then mechanism was proposed 40 years ago based purely on struc- Scheme 4: Biosynthesis of mitomycin C (MMC) 7. Page 3 of 36 (page number not for citation purposes) Beilstein Journal of Organic Chemistry 2009, 5, No. 33. Scheme 5: Mode of action of mitomycin C. tural considerations and has been accepted since [40]. Only the 3. The N–C3–C9a disconnection first reductive activation step has been questioned as to whether it proceeds by a one-electron reduction to give the semiquinone [41-44] or by a two-electron reduction to give the hydroquinone [45-47]. Studies have shown that one-electron reduction in an organic solvent can trigger formation of the semiquinone and the subsequent reaction cascade [42]. On the other hand, two- electron reduction led to formation of the stable hydroquinone, which can be oxidized back to the quinone in the presence of Scheme 6: The N–C3–C9a disconnection. oxygen [48]. Nonetheless, different results were observed in water where both one- and two-electron reductions gave the same DNA adducts. Moreover, the disproportion of the 3.1. Danishefsky. Mitomycin K (MMK) semiquinone in aqueous anaerobic medium is also very fast [49] The retrosynthetic approach of Danishefsky is based on an whereas under aqueous aerobic conditions, the semiquinone intramolecular Diels–Alder reaction between a nitrosoaryl and a reoxidizes to the quinone more quickly than it disproportion- suitably functionalized diene (Scheme 7) [19]. Historically, this ates [50]. Thus, the conclusion was made that in aqueous strategy was designed to synthesize the related natural product medium the same hydroquinone intermediate was responsible FR-900482, 4, but their investigations also led to this signi- for the reaction cascade. ficant and concise total synthesis of mitomycin K.
Load more

Recommended publications
  • Synthesis of Indole and Oxindole Derivatives Incorporating Pyrrolidino, Pyrrolo Or Imidazolo Moieties
    From DEPARTMENT OF BIOSCIENCES AT NOVUM Karolinska Institutet, Stockholm, Sweden SYNTHESIS OF INDOLE AND OXINDOLE DERIVATIVES INCORPORATING PYRROLIDINO, PYRROLO OR IMIDAZOLO MOIETIES Stanley Rehn Stockholm 2004 All previously published papers have been reproduced with permission from the publishers. Published and printed by Karolinska University Press Box 200, SE-171 77 Stockholm, Sweden © Stanley Rehn, 2004 ISBN 91-7140-169-5 Till Amanda Abstract The focus of this thesis is on the synthesis of oxindole- and indole-derivatives incorporating pyrrolidins, pyrroles or imidazoles moieties. Pyrrolidino-2-spiro-3’-oxindole derivatives have been prepared in high yielding three-component reactions between isatin, α-amino acid derivatives, and suitable dipolarophiles. Condensation between isatin and an α-amino acid yielded a cyclic intermediate, an oxazolidinone, which decarboxylate to give a 1,3-dipolar species, an azomethine ylide, which have been reacted with several dipolarophiles such as N- benzylmaleimide and methyl acrylate. Both N-substituted and N-unsubstituted α- amino acids have been used as the amine component. 3-Methyleneoxindole acetic acid ethyl ester was reacted with p- toluenesulfonylmethyl isocyanide (TosMIC) under basic conditions which gave (in a high yield) a colourless product. Two possible structures could be deduced from the analytical data, a pyrroloquinolone and an isomeric ß-carboline. To clarify which one of the alternatives that was actually formed from the TosMIC reaction both the ß- carboline and the pyrroloquinolone were synthesised. The ß-carboline was obtained when 3-ethoxycarbonylmethyl-1H-indole-2-carboxylic acid ethyl ester was treated with a tosylimine. An alternative synthesis of the pyrroloquinolone was performed via a reduction of a 2,3,4-trisubstituted pyrrole obtained in turn by treatment of a vinyl sulfone with ethyl isocyanoacetate under basic conditions.
    [Show full text]
  • Visible Light Photoredox Catalysis with Transition Metal Complexes: Application in Organic Synthesis
    Visible Light Photoredox Catalysis with Transition Metal Complexes: Application in Organic Synthesis Penghao Chen Dong Group Seminar April, 10th, 2013 Introduction Kalyanasundaram, K. Coord. Chem. Rev. 1982, 46, 159 Introduction Stern‐Volmer Relationship Turro, N. J. Modern Molecular Photochemistry; Benjamin/Cummings: Menlo Park, CA, 1978. Stoichiometric Net Reductive Reactionreductant1. Reduction is required of Electron Poor Olefin O Bn NH2 2 Pac, C. et. al., J. Am. Chem. Soc. 1981, 103, 6495 Net Reductive Reaction 2. Reductive Dehalogenation Fukuzumi, S. et. al., J. Phys. Chem. 1990, 94, 722. Net Reductive Reaction 2. Reductive Dehalogenation Stephenson, C. R. J. et. al., J. Am. Chem. Soc. 2009, 131, 8756. Stephenson, C. R. J. et. al., Nature Chem. 2012, 4, 854 Net Reductive Reaction 3. Radical Cyclization Stephenson, C. R. J. et. al., Chem. Commun. 2010, 46, 4985 Stephenson, C. R. J. et. al., Nature Chem. 2012, 4, 854 Net Reductive Reaction 4. Epoxide and Aziridine Opening Fensterbank, L. et. al., Angew. Chem., Int. Ed. 2011, 50, 4463 Hasegawa, E. et. al., Tetrahedron 2006, 62, 6581 Guindon, Y. et. al., Synlett 1998, 213 Guindon, Y. et. al., Synlett 1995, 449 Net Oxidative Reaction 1. Functional Group Reactions Cano‐Yelo, H.; Deronzier, A. Tetrahedron Lett. 1984, 25, 5517 Net Oxidative Reaction 1. Functional Group Reactions Jiao, N. et. al., Org. Lett. 2011, 13, 2168 Net Oxidative Reaction 1. Functional Group Reactions Jørgensen, K. A.; Xiao, W.‐J. Angew. Chem., Int. Ed. 2012, 51, 784 Net Oxidative Reaction 2. Oxid. Generation of Iminium Ions Stephenson, C. R. J. et. al., J. Am. Chem. Soc. 2010, 132, 1464 Net Oxidative Reaction 2.
    [Show full text]
  • Use of Anti-Vegf Antibody in Combination With
    (19) TZZ __T (11) EP 2 752 189 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/337 (2006.01) A61K 39/395 (2006.01) 26.10.2016 Bulletin 2016/43 A61P 35/04 (2006.01) A61K 31/513 (2006.01) A61K 31/675 (2006.01) A61K 31/704 (2006.01) (2006.01) (21) Application number: 13189711.8 A61K 45/06 (22) Date of filing: 20.11.2009 (54) USE OF ANTI-VEGF ANTIBODY IN COMBINATION WITH CHEMOTHERAPY FOR TREATING BREAST CANCER VERWENDUNG VON ANTI-VEGF ANTIKÖRPER IN KOMBINATION MIT CHEMOTHERAPIE ZUR BEHANDLUNG VON BRUSTKREBS UTILISATION D’ANTICORPS ANTI-VEGF COMBINÉS À LA CHIMIOTHÉRAPIE POUR LE TRAITEMENT DU CANCER DU SEIN (84) Designated Contracting States: (74) Representative: Denison, Christopher Marcus et al AT BE BG CH CY CZ DE DK EE ES FI FR GR HR Mewburn Ellis LLP HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT City Tower RO SE SI SK SM TR 40 Basinghall Street London EC2V 5DE (GB) (30) Priority: 22.11.2008 US 117102 P 13.05.2009 US 178009 P (56) References cited: 18.05.2009 US 179307 P US-A1- 2009 163 699 (43) Date of publication of application: • CAMERON ET AL: "Bevacizumab in the first-line 09.07.2014 Bulletin 2014/28 treatment of metastatic breast cancer", EUROPEAN JOURNAL OF CANCER. (60) Divisional application: SUPPLEMENT, PERGAMON, OXFORD, GB 16188246.9 LNKD- DOI:10.1016/S1359-6349(08)70289-1, vol. 6, no.
    [Show full text]
  • Priya Mathew
    PROGRESS TOWARDS THE TOTAL SYNTHESIS OF MITOMYCIN C By Priya Ann Mathew Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Chemistry August, 2012 Nashville, Tennessee Approved: Professor Jeffrey N. Johnston Professor Brian O. Bachmann Professor Ned A. Porter Professor Carmelo J. Rizzo ACKNOWLEDGMENTS I would like to express my gratitude to everyone who made my graduate career a success. Firstly, I would like to thank my advisor, Professor Jeffrey Johnston, for his dedication to his students. He has always held us to the highest standards and he does everything he can to ensure our success. During the challenges we faced in this project, he has exemplified the true spirit of research, and I am especially grateful to him for having faith in my abilities even when I did not. I would like to acknowledge all the past and present members of the Johnston group for their intellectual discussion and their companionship. In particular, I would like to thank Aroop Chandra and Julie Pigza for their incredible support and guidance during my first few months in graduate school, Jayasree Srinivasan who worked on mitomycin C before me, and Anand Singh whose single comment “A bromine is as good as a carbon!” triggered the investigations detailed in section 2.6. I would also like to thank the other members of the group for their camaraderie, including Jessica Shackleford and Amanda Doody for their friendship, Hubert Muchalski for everything related to vacuum pumps and computers, Michael Danneman and Ken Schwieter for always making me laugh, and Matt Leighty and Ki Bum Hong for their useful feedback.
    [Show full text]
  • Ginsenosides Synergize with Mitomycin C in Combating Human Non-Small Cell Lung Cancer by Repressing Rad51-Mediated DNA Repair
    Acta Pharmacologica Sinica (2018) 39: 449–458 © 2018 CPS and SIMM All rights reserved 1671-4083/18 www.nature.com/aps Article Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair Min ZHAO, Dan-dan WANG, Yuan CHE, Meng-qiu WU, Qing-ran LI, Chang SHAO, Yun WANG, Li-juan CAO, Guang-ji WANG*, Hai-ping HAO* State Key Laboratory of Natural Medicines, Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China The use of ginseng extract as an adjuvant for cancer treatment has been reported in both animal models and clinical applications, but its molecular mechanisms have not been fully elucidated. Mitomycin C (MMC), an anticancer antibiotic used as a first- or second- line regimen in the treatment for non-small cell lung carcinoma (NSCLC), causes serious adverse reactions when used alone. Here, by using both in vitro and in vivo experiments, we provide evidence for an optimal therapy for NSCLC with total ginsenosides extract (TGS), which significantly enhanced the MMC-induced cytotoxicity against NSCLC A549 and PC-9 cells in vitro when used in combination with relatively low concentrations of MMC. A NSCLC xenograft mouse model was used to confirm thein vivo synergistic effects of the combination of TGS with MMC. Further investigation revealed that TGS could significantly reverse MMC-induced S-phase cell cycle arrest and inhibit Rad51-mediated DNA damage repair, which was evidenced by the inhibitory effects of TGS on the levels of phospho- MEK1/2, phospho-ERK1/2 and Rad51 protein and the translocation of Rad51 from the cytoplasm to the nucleus in response to MMC.
    [Show full text]
  • The Role of Drug Transport in Resistance to Nitrogen Mustard and Other Alkylating Agents in L5178Y Lymphoblasts1
    [CANCER RESEARCH 35.1687 1692, July 1975] The Role of Drug Transport in Resistance to Nitrogen Mustard and Other Alkylating Agents in L5178Y Lymphoblasts1 Gerald J. Goldenberg2 Department of Medicine. University of Manitoba, and the Manitoba Institute of Cell Biology. Winnipeg. Manitoba. R3E OV9, Canada SUMMARY (19, 20) in normal and leukemic human lymphoid cells (25) and in rat Walker 256 carcinosarcoma cells in vitro (18). An investigation was undertaken of the mechanism of Choline, a close structural analog of HN2, has been resistance to nitrogen mustard (HN2) and other alkylating identified as the native substrate for the HN2 transport agents, with particular emphasis on the interaction between system (19). Other alkylating agents, including chlorambu cross-resistance and drug transport mechanisms in LSI78Y cil, melphalan, and intact and enzyme-activated cyclophos lymphohlasts. Dose-survival curves demonstrated that the DOfor HN2-sensitive cells (L5178Y) treated with HN2 in phamide, did not inhibit HN2 transport, suggesting inde vitro was 9.79 ng/ml and the D0 for HN2-resistant cells pendent transport mechanisms for these agents (20). Unlike HN2 transport, a study of cyclophosphamide uptake by (L5178Y/HN2) was 181.11 ng/ml; thus, sensitive cells were 18.5-fold more responsive than were resistant cells and the LSI78Y lymphoblasts demonstrated biphasic kinetics and was mediated by a facilitated diffusion mechanism (15). In difference was highly significant (p < 0.001). A similar common with HN2 transport, uptake of cyclophosphamide evaluation of 5 additional alkylating agents, including chlorambucil, melphalan, l,3-bis(2-chloroethyl)-l-nitro- was not blocked by other alkylating agents such as HN2, sourea, Mitomycin C, and 2,3,5-tris(ethyleneimino)-l,4- chlorambucil, melphalan and isophosphamide, providing additional evidence that these drugs are transported by benzoquinone, revealed that L5178Y/HN2 cells were also cross-resistant, in part, to each of these compounds.
    [Show full text]
  • Antibiotics for Cancer Treatment
    Journal of Cancer 2020, Vol. 11 5135 Ivyspring International Publisher Journal of Cancer 2020; 11(17): 5135-5149. doi: 10.7150/jca.47470 Review Antibiotics for cancer treatment: A double-edged sword Yuan Gao1,2, Qingyao Shang1,2, Wenyu Li1,2, Wenxuan Guo1, Alexander Stojadinovic3, Ciaran Mannion3,4, Yan-gao Man3 and Tingtao Chen1 1. National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, 1299 Xuefu Road, Honggu District, Nanchang, 330031 People’s Republic of China. 2. Queen Mary School, Nanchang University, Nanchang, Jiangxi 330031, PR China. 3. Department of Pathology, Hackensack University Medical Center, 30 Prospec Avenue, Hackensack, NJ 07601, USA. 4. Department of Pathology, Hackensack Meridian School of Medicine at Seton Hall University, 340 Kingsland Street, Nutley, NJ 07110, USA. Corresponding author: Dr. Tingtao Chen Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, PR China; E-mail: [email protected]; Tel: +86-791-83827170, or Dr. Yan-gao Man, Man Department of Pathology, Hackensack Meridian Health-Hackensack University Medical Center, NJ, USA; e-mail: [email protected]. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.04.27; Accepted: 2020.06.14; Published: 2020.06.28 Abstract Various antibiotics have been used in the treatment of cancers, via their anti-proliferative, pro-apoptotic and anti-epithelial-mesenchymal-transition (EMT) capabilities. However, increasingly studies have indicated that antibiotics may also induce cancer generation by disrupting intestinal microbiota, which further promotes chronic inflammation, alters normal tissue metabolism, leads to genotoxicity and weakens the immune response to bacterial malnutrition, thereby adversely impacting cancer treatment.
    [Show full text]
  • Dppm-Derived Phosphonium Salts and Ylides As Ligand Precursors for S-Block Organometallics
    Issue in Honor of Prof. Rainer Beckert ARKIVOC 2012 (iii) 210-225 Dppm-derived phosphonium salts and ylides as ligand precursors for s-block organometallics Jens Langer,* Sascha Meyer, Feyza Dündar, Björn Schowtka, Helmar Görls, and Matthias Westerhausen Institute of Inorganic and Analytical Chemistry, Friedrich-Schiller-University Jena Humboldtstraße 8, D-07743 Jena, Germany E-mail: [email protected] Dedicated to Professor Rainer Beckert on the Occasion of his 60th Birthday DOI: http://dx.doi.org/10.3998/ark.5550190.0013.316 Abstract The addition reaction of 1,1-bis(diphenylphosphino)methane (dppm) and haloalkanes R-X yields the corresponding phosphonium salts [Ph2PCH2PPh2R]X (1a: R = Me, X = I; 1b: R = Et, X = Br; 1c: R = iPr, X = I; 1d: R = CH2Mes, X = Br; 1e: R = tBu, X = Br). In case of the synthesis of 1e, [Ph2MePH]Br (3) was identified as a by-product. Deprotonation of 1 by KOtBu offers access to the corresponding phosphonium ylides [Ph2PCHPPh2R] (2a: R = Me; 2b: R = Et; 2c: R = iPr; 2d: R = CH2Mes) in good yields. Further deprotonation of 2a using n-butyllithium allows the isolation of the lithium complex [Li(Ph2PCHPPh2CH2)]n (4) and its monomeric tmeda adduct [(tmeda)Li(Ph2PCHPPh2CH2)] (4a). All compounds were characterized by NMR measurements and, except of 4, by X-ray diffraction experiments. Keywords: Phosphonium salt, phosphonium ylide, lithium, lithium phosphorus coupling Introduction Phosphonium ylides gained tremendous importance in organic chemistry, since Wittig and co- workers developed their alkene synthesis in the
    [Show full text]
  • EFFORTS TOWARD the TOTAL SYNTHESIS of MITOMYCINS By
    EFFORTS TOWARD THE TOTAL SYNTHESIS OF MITOMYCINS by ANNE VIALETTES Ingénieur de l’École Supérieure de Chimie, Physique Électronique de Lyon, spécialité: Chimie - Chimie des Procédés, 2007 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE DEGREE OF MASTER OF SCIENCE in THE FACULTY OF GRADUATE STUDIES (Chemistry) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) May 2009 © Anne Vialettes, 2009 ABSTRACT This thesis describes our efforts toward the total synthesis of mitomycins. The centerpiece of our route to the target molecule is a homo-Brook mediated aziridine fragmentation, developed in our laboratory. The aziridine moiety of the target molecule was installed through an intramolecular iodoamidification of an olefin. The crystalline triazoline intermediate, available before the homo-Brook rearrangement, was obtained after Reetz allylation on an aldehyde followed by a intramolecular 1,3-diploar cycloaddition of an azido unit onto a terminal olefin. The aldehyde intermediate was synthesized in 9 steps involving a Mitsunobu reaction, a Claisen rearrangement and a Lemieux-Johnson oxidation from readily commercially available products. ii TABLE OF CONTENTS ABSTRACT ....................................................................................................................................ii TABLE OF CONTENTS ..................................................................................................................iii LIST OF FIGURES .........................................................................................................................
    [Show full text]
  • Nitrogen, Oxygen and Sulfur Ylide Chemistry; Edited by JS Clark
    1134 BOOKREVIEW Nitrogen, Oxygen and Sulfur Ylide Chemistry; edited fer protocol midway through. In addition to the carbene- by J. S. Clark; Oxford University Press: Oxford, 2002; and carbenoid-mediated methods in this chapter, two sec- hardback, £80.00, pp 292, ISBN 0-19-850017-3. tions by Sato deal with the desilylation of α-silylated ammonium and sulfonium salts. Ammonium and sulfonium ylides have been recognised The following chapter, on azomethine, carbonyl and thio- and utilised as intermediates in various reactions since carbonyl ylides, encompasses a wider range of synthetic the discovery of the Stevens rearrangement some sev- methods. In addition to the use of diazo compounds in enty-five years ago. In the past two or three decades, both intra- and intermolecular reactions, there are sec- however, the field has undergone a rapid expansion and tions on the generation of azomethine ylides by conden- now incorporates many useful transformations of oxo- sation of amines with aldehydes and by oxidation of nium, as well as ammonium and sulfonium ylides. The bis(silylmethyl)amines, and on the generation of carbo- reasons for this expansion are twofold – firstly, there has nyl ylides by reduction of bis(chloroalkyl)ethers. The been a recognition of the power and versatility of these final short chapter, on nitrile ylide chemistry, covers two intermediates for synthesis of complex organic mole- methods: the reaction of nitriles with metal carbenes and cules; and secondly, catalytic methods for their genera- the thermolysis of oxazaphospholines. tion have been developed which are milder, cleaner and Overall, the book achieves its aim of providing a useful more flexible than the traditional method of salt deproto- introduction to modern practical methods in ylide chem- nation.
    [Show full text]
  • The Synthesis of Tryptophan Derivatives, 2
    Graduate Theses, Dissertations, and Problem Reports 2009 The synthesis of tryptophan derivatives, 2- and/or 3-substituted indoles, progress toward dilemmaones A-C, and synthetic studies towards fistulosin via palladium-catalyzed reductive N- heteroannulation Christopher Andrew Dacko West Virginia University Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Dacko, Christopher Andrew, "The synthesis of tryptophan derivatives, 2- and/or 3-substituted indoles, progress toward dilemmaones A-C, and synthetic studies towards fistulosin via palladium-catalyzed reductive N-heteroannulation" (2009). Graduate Theses, Dissertations, and Problem Reports. 4454. https://researchrepository.wvu.edu/etd/4454 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. The Synthesis of Tryptophan Derivatives, 2- and/or 3- Substituted Indoles, Progress Toward Dilemmaones A-C, and Synthetic Studies Towards Fistulosin via Palladium-Catalyzed Reductive N-Heteroannulation Christopher Andrew Dacko Dissertation submitted to the Eberly College of Arts and Sciences at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry Björn C.
    [Show full text]
  • Possible Intermediates in the Action of Adriamycin a Pulse Radiolysis Study E.J
    Br. J. Cancer (1985), 51, 515-523 Possible intermediates in the action of adriamycin A pulse radiolysis study E.J. Land', T. Mukherjeel*, A.J. Swallow' & J.M. Bruce2 'Paterson Laboratories, Christie Hospital and Holt Radium Institute, Manchester, M20 9BX and the 2Department of Chemistry, The University, Manchester M13 9PL, UK. Summary Over a wide range of pH, the semiquinone free radicals formed by reduction of adriamycin exist as a form which is strongly stabilised by internal hydrogen bonding and resonance. They protonate with pKa = 2.9. Below this pH they exhibit absorption maxima at 430nm (smax = 13,200dm3mol-'cm-1) and -720nm (Cmax =4,200dm3mol3-1 cm -). Above pH 2.9 they have maxima at 480 nm (smax= 14,600 dM3mol-1 cm-') and - 700 nm (Smax = 3,400 dm mol -cm -'). In acid and alkaline solution the radicals rapidly disappear by disproportionation, but within the approximate pH range 6 to 11 they appear to be relatively stable for at least 10-20ms, existing in transient equilibrium with parent adriamycin and the full reduced form. Some rate constants for the formation and reactions of the semiquinone are given, including the reaction with oxygen to give 0i-. Fully reduced adriamycin has absorption maxima at 410 nm (smax = 11,000dm3 mol-lcm-') at pH 5 and 430 nm (Vmax=19,000dm3mol- cm -) at pH 11. It undergoes decomposition within a few hundred ms. The intermediates from daunomycin would be expected to have properties similar to those from adriamycin. Anthracycline antibiotics constitute a major class of or hydroxyl (OH'), which could react with the chemotherapeutic agents for the treatment of proximal DNA, producing the strand-scission different kinds of cancer.
    [Show full text]